• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.

作者信息

Joensuu H, Klemi P J, Söderström K O, Jalkanen S

机构信息

Department of Radiotherapy, Turku University Central Hospital, Finland.

出版信息

Cancer. 1991 Oct 1;68(7):1564-71. doi: 10.1002/1097-0142(19911001)68:7<1564::aid-cncr2820680718>3.0.co;2-#.

DOI:10.1002/1097-0142(19911001)68:7<1564::aid-cncr2820680718>3.0.co;2-#
PMID:1893358
Abstract

The prognostic value of S-phase fraction (SPF), determined by flow cytometric study from paraffin-embedded tissue, and grading by Working Formulation (WF) and Kiel classification were compared among 245 patients with non-Hodgkin's lymphoma followed for the median of 89 months or until death. Histologic reclassification and SPF determinations were done without knowledge on clinical data. SPF (P equals 0.0001), WF (P equals 0.0003), and Kiel classification (P equals 0.0008) were associated with mortality in lymphoma in a univariate analysis, and WF and SPF were independent prognostic factors in Cox's multivariate analysis. Although SPF correlated strongly both with WF and Kiel grades (P less than 0.0001), low-grade and high-grade malignant lymphomas according to Kiel classification, and high-grade lymphomas according to WF could be divided into groups with significantly different outcome by SPF. The results suggests a role for SPF in therapeutic decision-making.

摘要

相似文献

1
Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Cancer. 1991 Oct 1;68(7):1564-71. doi: 10.1002/1097-0142(19911001)68:7<1564::aid-cncr2820680718>3.0.co;2-#.
2
Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.治疗对非霍奇金淋巴瘤S期分数预后价值的影响。
J Clin Oncol. 1994 Oct;12(10):2167-75. doi: 10.1200/JCO.1994.12.10.2167.
3
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.流式细胞术检测的S期细胞分数作为非霍奇金淋巴瘤细胞学分级的补充生物学参数。
Diagn Cytopathol. 2003 Oct;29(4):194-9. doi: 10.1002/dc.10298.
4
Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Cancer. 1990 Jun 1;65(11):2564-71. doi: 10.1002/1097-0142(19900601)65:11<2564::aid-cncr2820651128>3.0.co;2-p.
5
Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Pol J Pathol. 1999;50(1):23-9.
6
[Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].[恶性非霍奇金淋巴瘤的组织学分类与患者生存率: Kiel 分类法与工作分类法的比较]
Verh Dtsch Ges Pathol. 1992;76:110-6.
7
Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
J Tongji Med Univ. 1992;12(2):65-70. doi: 10.1007/BF02887782.
8
Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.淋巴细胞归巢受体和S期分数在非霍奇金淋巴瘤中的预后价值
Blood. 1990 Apr 1;75(7):1549-56.
9
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
Haematologica. 1992 Jan-Feb;77(1):84-6.
10
Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material.非霍奇金淋巴瘤中增殖细胞核抗原(PCNA):与福尔马林固定石蜡包埋材料中的工作分类法及 Kiel 分类法的相关性
Pathology. 1996 Jan;28(1):12-6. doi: 10.1080/00313029600169423.

引用本文的文献

1
Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.淋巴细胞归巢受体(CD44)的表达与胃肠道淋巴瘤的不良预后相关。
Br J Cancer. 1993 Aug;68(2):428-32. doi: 10.1038/bjc.1993.354.
2
Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.增殖细胞核抗原(PCNA)作为非霍奇金淋巴瘤的一个预后因素。
Br J Cancer. 1992 Oct;66(4):739-43. doi: 10.1038/bjc.1992.349.